QuickView for guanylate cyclase regulator activity (biogroup)

1. Uveal melanomas with differential syntenin-1 expression and other clinical attributes
2. L1000 CMAP - Pancreatic cancer YAPC.311 cells with CRISPR-targeted gene knockouts
3. L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
4. L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
5. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens

There were no matches for guanylate cyclase regulator activity

1. Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Admini…
2. A Study in Healthy Adult Male Participants to Learn the Way Vericiguat is Absorbed With and Without …
3. Medical Management of Late Intrauterine Death.
4. The Effect of Vericiguat on Peripheral Vascular Function, Patient Health Status and Inflammation
5. Evaluating MED2005 & Nitrostat Bioavailability